MedPath

Drug to prevent lung injury secondary to COVID 19

Not Applicable
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/12/029613
Lead Sponsor
Department of anaesthesiology AIIMS Rishikesh
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age 18 years or older, with Endotracheal tube or Noninvasive ventilation in place, intubated/put on NIV yesterday or today with PaO2 to FIO2 ratio less than or equal to 300

Exclusion Criteria

1. Heparin allergy or heparin-induced thrombocytopaenia

2. APTT > 120 seconds and this is not due to anticoagulant therapy

3. Platelet count < 20 x 109 per L

4.Pulmonary bleeding, which is frank bleeding in the trachea, bronchi or lungs with repeated haemoptysis or requiring repeated suctioning

5. Uncontrolled bleeding

6. Pregnant or suspected pregnancy (Urine or serum HCG will be recorded)

7. Receiving or about to commence ECMO or HFOV

8. Death is imminent or inevitable within 24 hours

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary Outcome Measures: <br/ ><br>1.D-dimer profile [ Time Frame: Up to day 10 days. ] <br/ ><br>2.NLR ratio [Time frame up to 10 days] <br/ ><br>3.Mean daily PaO2 to FiO2 ratio [ Time Frame: 10 days ] <br/ ><br>Timepoint: Primary Outcome Measures: <br/ ><br>1.D-dimer profile [ Time Frame: Up to day 10 days. ] <br/ ><br>2.NLR ratio [Time frame up to 10 days] <br/ ><br>3.Mean daily PaO2 to FiO2 ratio [ Time Frame: 10 days ] <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1.Oxygenation Index, as assessed by Po2 <br/ ><br>2.Quasi-Static Lung Compliance [ Time Frame: Up to day 10] Determine the effect of nebulised heparin on Quasi-Static Lung Compliance (i.e. tidal volume/(Plateau pressure-PEEP) <br/ ><br>3.Time to separation from invasive ventilationTimepoint: day 1,3 and 10
© Copyright 2025. All Rights Reserved by MedPath